Gene editing firm Locus Biosciences adds another $7M to its 2020 cash haul
Gene editing startup Locus Biosciences has landed another $7 million in new cash, adding to a year that has brought commitments of nearly $100 million.
Read More
genetic therapy
Gene therapy firm AskBio acquires French company targeting deadly brain disease
Asklepios BioPharmaceutical (AskBio), a clinical stage gene therapy company in Research Triangle Park, has acquired BrainVectis, a French company that is developing a potential gene therapy for Huntington’s disease, a fatal genetic disease of the brain.
Read More
New gene therapy drug comes with a $2.1M treatment price tag
The US Food and Drug Administration approved a treatment Friday for a genetic disease called spinal muscular atrophy that causes infants’ muscles to waste away, potentially killing them before age 2. But the price is steep.
Read More
French firm Cellectis investment, jobs to boost NC’s gene therapy prominence
Paris-based biotechnology company Cellectis plans to invest nearly $70 million and create 200 jobs in Raleigh, at what will become its first North American manufacturing facility.
Read More
NC officials, biotech company AveXis announce expansion
North Carolina may bring to an end today a recent streak of more bad news than good when it comes to economic development projects.
Read More
Roche buying gene testing firm Foundation Medicine in $2.4B deal
Swiss drug giant Roche is buying Foundation Medicine, which has a key hub in Morrisville, in a $2.4B deal.
Read More
Novartis-owned AveXis bringing $55M gene therapy factory, 200 jobs to Durham
AveXis, an Illinois-based clinical-stage company developing gene therapies for neurological genetic diseases, is investing $55 million in a new Durham manufacturing facility that will create 200 jobs.
Read More
